ASP-VAL-ALA-HIS-GLY-ILE-LEU-ASN-GLU-ALA-TYR-ARG-LYS-VAL-LEU-ASP-GLN-LEU-SER-ALA-GLY-LYS-HIS-LEU-GLN-SER-LEU-VAL-ALA
生物活性体外研究 用途与合成方法 MSDS ASP-VAL-ALA-HIS-GLY-ILE-LEU-ASN-GLU-ALA-TYR-ARG-LYS-VAL-LEU-ASP-GLN-LEU-SER-ALA-GLY-LYS-HIS-LEU-GLN-SER-LEU-VAL-ALA价格(试剂级) 上下游产品信息
| 中文名称 | ASP-VAL-ALA-HIS-GLY-ILE-LEU-ASN-GLU-ALA-TYR-ARG-LYS-VAL-LEU-ASP-GLN-LEU-SER-ALA-GLY-LYS-HIS-LEU-GLN-SER-LEU-VAL-ALA |
|---|---|
| 中文同义词 | 人PACAP-RELATED PEPTIDE (PRP)肽 |
| 英文名称 | DVAHGILNEAYRKVLDQLSAGKHLQSLVA |
| 英文同义词 | H-ASP-VAL-ALA-HIS-GLY-ILE-LEU-ASN-GLU-ALA-TYR-ARG-LYS-VAL-LEU-ASP-GLN-LEU-SER-ALA-GLY-LYS-HIS-LEU-GLN-SER-LEU-VAL-ALA-OH;DVAHGILNEAYRKVLDQLSAGKHLQSLVA;PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE-RELATED PEPTIDE (HUMAN);PITUITARY ADENYLATE CYCLASE ACTIVATING PEPTIDE-RELATED PEPTIDE, HUMAN;PACAP-RELATED PEPTIDE (HUMAN);PACAP-RELATED PEPTIDE (PRP), HUMAN;PRP (HUMAN);ASP-VAL-ALA-HIS-GLY-ILE-LEU-ASN-GLU-ALA-TYR-ARG-LYS-VAL-LEU-ASP-GLN-LEU-SER-ALA-GLY-LYS-HIS-LEU-GLN-SER-LEU-VAL-ALA |
| CAS号 | |
| 分子式 | C139H229N41O42 |
| 分子量 | 3146.56 |
| EINECS号 | |
| 相关类别 | 多肽;Peptide |
| Mol文件 | Mol File |
| 结构式 |  |
ASP-VAL-ALA-HIS-GLY-ILE-LEU-ASN-GLU-ALA-TYR-ARG-LYS-VAL-LEU-ASP-GLN-LEU-SER-ALA-GLY-LYS-HIS-LEU-GLN-SER-LEU-VAL-ALA 性质
ASP-VAL-ALA-HIS-GLY-ILE-LEU-ASN-GLU-ALA-TYR-ARG-LYS-VAL-LEU-ASP-GLN-LEU-SER-ALA-GLY-LYS-HIS-LEU-GLN-SER-LEU-VAL-ALA 用途与合成方法
PACAP-Related Peptide (PRP), human 是一种垂体腺苷酸环化酶激活肽 (PACAP) 的前体蛋白，含有 29 个氨基酸残基。
PACAP-Related Peptide (PRP) has a distinct biological activity on the gallbladder that is similar to pituitary adenylate cyclase activating polypeptide (PACAP) but opposite to that of vasoactive intestinal polyprptide (VIP); and its related peptide, peptide histidine methlonmc (PHM).